CRL - Charles River Laboratories International, Inc.
NYSE - NYSE Delayed price. Currency in USD
Currency in USD
Valuation measures4
| Market cap (intra-day) | 9.79B |
| Enterprise value | 12.65B |
| Trailing P/E | 20.17 |
| Forward P/E | 18.28 |
| PEG ratio (5-yr expected) | 1.26 |
| Price/sales (ttm) | 2.47 |
| Price/book (mrq) | 3.29 |
| Enterprise value/revenue | 3.09 |
| Enterprise value/EBITDA | 12.25 |
Trading information
Stock price history
| Beta (5Y monthly) | 1.34 |
| 52-week change 3 | -17.07% |
| S&P500 52-week change 3 | 1.77% |
| 52-week high 3 | 262.00 |
| 52-week low 3 | 181.22 |
| 50-day moving average 3 | 195.91 |
| 200-day moving average 3 | 214.39 |
Share statistics
| Avg vol (3-month) 3 | 561.4k |
| Avg vol (10-day) 3 | 590.22k |
| Shares outstanding 5 | 51.18M |
| Implied shares outstanding 6 | N/A |
| Float 8 | 50.58M |
| % held by insiders 1 | 0.98% |
| % held by institutions 1 | 99.00% |
| Shares short (14 May 2023) 4 | 1.34M |
| Short ratio (14 May 2023) 4 | 2.22 |
| Short % of float (14 May 2023) 4 | 3.00% |
| Short % of shares outstanding (14 May 2023) 4 | 2.62% |
| Shares short (prior month 13 Apr 2023) 4 | 1.38M |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | N/A |
| Last split date 3 | N/A |
Financial highlights
Fiscal year
| Fiscal year ends | 30 Dec 2022 |
| Most-recent quarter (mrq) | 31 Mar 2023 |
Profitability
| Profit margin | 12.13% |
| Operating margin (ttm) | 16.41% |
Management effectiveness
| Return on assets (ttm) | 5.68% |
| Return on equity (ttm) | 17.21% |
Income statement
| Revenue (ttm) | 4.09B |
| Revenue per share (ttm) | 80.34 |
| Quarterly revenue growth (yoy) | 12.60% |
| Gross profit (ttm) | 1.46B |
| EBITDA | 977.24M |
| Net income avi to common (ttm) | 496.34M |
| Diluted EPS (ttm) | 9.47 |
| Quarterly earnings growth (yoy) | 10.90% |
Balance sheet
| Total cash (mrq) | 201.59M |
| Total cash per share (mrq) | 3.94 |
| Total debt (mrq) | 3.17B |
| Total debt/equity (mrq) | 100.38 |
| Current ratio (mrq) | 1.48 |
| Book value per share (mrq) | 60.74 |
Cash flow statement
| Operating cash flow (ttm) | 626.39M |
| Levered free cash flow (ttm) | 258.57M |
© 2023 Yahoo. All rights reserved.